Pfizer Says Moderna Telling FDA One Thing, PTAB Another
By Andrew Karpan · January 30, 2024, 4:42 PM EST
Pfizer has told the Patent Trial and Appeal Board that the language Moderna used to quickly gain approval from the U.S. Food and Drug Administration for its COVID-19 vaccines should doom...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login